## Abstract A study was undertaken to determine the prevalence and risk factors for serological evidence of hepatitis C virus (HCV) infection in patients infected with the human immunodeficiency virus (HIV). Tests for antiβHCV antibody were carried out by enzymeβlinked immunoassay (EIA) on 101 HIVβ
Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection
β Scribed by Ruxandra Enzensberger; W. Braun; Ch. July; H. W. Doerr; Eilke B. Helm
- Publisher
- Springer-Verlag
- Year
- 1991
- Tongue
- English
- Weight
- 948 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0300-8126
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Antiphospholipid (aPL) and antiplatelet (aPlt) antibodies, found in patients with autoimmune diseases, are also detected in infectious diseases. The purpose of this study was to examine the prevalence of these antibodies in HIV patients and to evaluate an association of these antibodies
## Abstract Relatively little is known about the role of hepatitis B virus (HBV) genotype G (HBV/G) in patients coβinfected with human immunodeficiency virus (HIV) and HBV. This study examined the prevalence and association of HBV/G to liver fibrosis in coβinfected patients. HBV genotypes were dete
Prevalence of GBV-C/HGV was determined in a cohort of HIV-infected patients, via a reverse transcription-polymerase chain reaction detection of RNA in serum, amplifying the NS5 region of GBV-C/HGV genome. GBV-C/HGV RNA was detected in 143 (37.7%) of 379 patients, with similar results in the differen
A seroepidemiological evaluation of the humoral immune response against human herpes viruses was carried out in patients with and without HIV infection in Tanzania to study the role of these viruses as a cofactor in AIDS. Serum specimens were obtained from 321 outpatients and 100 healthy schoolchild
Hepatitis B virus (HBV) resistance to lamivudine has not been extensively documented in human immunodeficiency virus (HIV)-infected patients. We studied the long-term incidence of HBV resistance to lamivudine in HIV-positive patients. Sixty-six HIV-HBV-coinfected patients were studied while receivin